Studies have shown that the activation of the GnRH receptor signaling pathway is closely related to the growth of uterine leiomyomas, and changes in NAV3 expression may regulate this pathway through a feedback mechanism, thereby affecting tumor progression (Kakar et al., 2025). This evidence concerns the gene GNRHR and uterine corpus leiomyoma.